However, comprehensive molecular testing and functional validation allowed us to reclassify the patient as having XLP-1 with dysgammaglobulinemia case, demonstrating that normal SAP expression does not necessarily correlate with normal functional activity. Here, SH2D1A is linked to dysgammaglobulinemia.